| OTC Markets: PBIO
Pressure BioSciences, Inc. ("PBI") is a life sciences tools company focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on our game-changing Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels (58,000 psi or greater) to safely, conveniently and reproducibly control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. We currently focus the majority of our efforts on the development and sale of PCT-enhanced systems (instruments and consumables) to address the challenging problems inherent in biological sample preparation, a crucial laboratory step performed by scientists worldwide working in biological life sciences research. The Company believes that biological sample preparation is a $6 billion market. Through June 30, 2012, we have installed over 220 PCT Systems in leading academic, government, biotech, and pharma companies worldwide. PCT advantages include: (a) extraction of more membrane proteins, (b) enhanced proteolysis, (c) differential lysis in a mixed sample base, (d) pathogen inactivation, (e) increased DNA detection, and (f) exquisite control of the sample preparation process. Primary PCT uses include biomarker discovery, forensics, and histology.